These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8743405)
1. Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats. Kurihara A; Shibayama Y; Yasuno A; Ikeda M; Hisaoka M Biopharm Drug Dispos; 1996 May; 17(4):343-53. PubMed ID: 8743405 [TBL] [Abstract][Full Text] [Related]
2. Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution. Kurihara A; Shibayama Y; Mizota A; Yasuno A; Ikeda M; Sasagawa K; Kobayashi T; Hisaoka M Biopharm Drug Dispos; 1996 May; 17(4):331-42. PubMed ID: 8743404 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats. Kurihara A; Shibayama Y; Mizota A; Yasuno A; Ikeda M; Hisaoka M Biol Pharm Bull; 1996 Feb; 19(2):252-8. PubMed ID: 8850317 [TBL] [Abstract][Full Text] [Related]
4. Species variation in pharmacokinetics and opsonization of palmitoyl rhizoxin (RS-1541) incorporated in lipid emulsions. Kurihara A; Shibayama Y; Kasuya A; Ikeda M; Hisaoka M J Drug Target; 1998; 5(6):491-505. PubMed ID: 9783680 [TBL] [Abstract][Full Text] [Related]
5. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions. Sakaeda T; Hirano K J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695 [TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice. Kurihara A; Shibayama Y; Mizota A; Yasuno A; Ikeda M; Sasagawa K; Kobayashi T; Hisaoka M Pharm Res; 1996 Feb; 13(2):305-10. PubMed ID: 8932454 [TBL] [Abstract][Full Text] [Related]
7. In vitro release, pharmacokinetic and tissue distribution studies of doxorubicin hydrochloride (Adriamycin HCl) encapsulated in lipiodolized w/o emulsions and w/o/w multiple emulsions. Lin SY; Wu WH; Lui WY Pharmazie; 1992 Jun; 47(6):439-43. PubMed ID: 1409841 [TBL] [Abstract][Full Text] [Related]
8. Topical delivery of lipophilic drugs from o/w Pickering emulsions. Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516 [TBL] [Abstract][Full Text] [Related]
10. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection]. Tian LL; Tang X; He HB; Wang J Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the quality of various vegetable oil emulsions on phagocytotic activity of the reticuloendothelial system in the rat]. Pipy B; Gaillard D; Derache R Ann Nutr Aliment; 1975; 29(4):271-84. PubMed ID: 1241257 [TBL] [Abstract][Full Text] [Related]
12. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132 [TBL] [Abstract][Full Text] [Related]
13. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899 [TBL] [Abstract][Full Text] [Related]
14. Prolonged circulation of menatetrenone by emulsions with hydrogenated castor oils in rats. Ueda K; Furukawa T; Kawaguchi Y; Miki Y; Sakaeda T; Iwakawa S J Control Release; 2004 Feb; 95(1):93-100. PubMed ID: 15013236 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. Chansri N; Kawakami S; Yamashita F; Hashida M Int J Pharm; 2006 Sep; 321(1-2):42-9. PubMed ID: 16790329 [TBL] [Abstract][Full Text] [Related]
16. Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins. Seki J; Sonoke S; Saheki A; Koike T; Fukui H; Doi M; Mayumi T Int J Pharm; 2004 May; 275(1-2):239-48. PubMed ID: 15081154 [TBL] [Abstract][Full Text] [Related]
17. Preparation and physical characterization of a novel marine oil emulsion as a potential new formulation vehicle for lipid soluble drugs. Cui G; Wang L; Davis PJ; Kara M; Liu H Int J Pharm; 2006 Nov; 325(1-2):180-5. PubMed ID: 16901663 [TBL] [Abstract][Full Text] [Related]
18. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Fatouros DG; Bergenstahl B; Mullertz A Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543 [TBL] [Abstract][Full Text] [Related]
19. Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy. Dierling AM; Sloat BR; Cui Z Eur J Pharm Biopharm; 2006 Apr; 62(3):275-81. PubMed ID: 16274979 [TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]